Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
NEW YORK (Reuters Health) – Patients undergoing endoscopic retrograde cholangiopancreatography (ERCP) and biliary stent placement are more likely to develop pancreatitis after the procedure than those not requiring…
NEW YORK (Reuters Health) – Rates of major adverse cardiovascular events (MACEs) are lower in hypertensive patients with coronary artery disease on amlodipine when candesartan is added to…
NEW YORK (Reuters Health) – Injecting bone cement into acute osteoporotic compression fractures leads to almost immediate and long-lasting pain relief – and at reasonable cost, a European…
NEW YORK (Reuters Health) – Very elderly patients with ST-segment elevation MI can do quite well with successful primary percutaneous intervention, as long they aren’t in cardiogenic shock…
NEW YORK (Reuters Health) – Concerns that bisphosphonate drugs used to treat osteoporosis might increase the risk of developing esophageal cancer have been put to rest by a…
NEW YORK (Reuters Health) – Patients who have undergone prior systemic therapies for cutaneous T-cell lymphoma may respond well to treatment with romidepsin, a potent inhibitor of histone…
NEW YORK (Reuters Health) – The response rate with standard treatment of hepatitis C infection is doubled when a hepatitis C virus (HCV) protease inhibitor, boceprevir, is added…
NEW YORK (Reuters Health) – When target cholesterol levels are not achieved with statin monotherapy in patients with mixed dyslipidemia, adding fenofibrate can tip the scales favorably. Dr.…
NEW YORK (Reuters Health) – Patients on warfarin need not discontinue treatment when they have a fecal occult blood test (FOBT), as it does not affect the predictive…
NEW YORK (Reuters Health) – In women undergoing in vitro fertilization, hormonal support with progesterone plus estradiol supplementation during the luteal phase after embryo transfer improves pregnancy and…
